Economy
-
-
China’s central bank to inject $149 billion daily before holidays
-
General Mills beats first-quarter sales estimates
-
AC Immune reports positive phase 2 trial results for ACI-7104
-
Abasca files technical report for Loki graphite deposit in Canada
-
Guggenheim upgrades Editas Medicine stock rating on gene editing therapy
-
UBS reiterates Buy on Royal Caribbean stock on TUI cruise data
-
Analysis-There’s a reason Trump is the only one talking about 1% rates
-
Seer technology to be featured in Singapore population health study
-
Cognizant reports 37% cost savings in Odyssey platform rebuild